CStone and IMPACT Therapeutics’ clinical collaboration progresses to IND filing acceptance for CS1001+IMP4297 combination therapy Life Science
HiberCell Launches With $60.75 Million Series A to Target Dormant Metastatic Cancer Cells Life Science
Frazier Healthcare Partners Launches Recida Therapeutics to Develop Novel Therapeutics for Serious Antibiotic-Resistant Infections Life Science